• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical evaluation of serum alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) levels in patients with hepatocellular carcinoma following interventional radiology.

作者信息

Minakuchi K, Murata K, Kaminoh T, Takada K, Takashima S, Nakamura K, Onoyama Y

机构信息

Department of Radiology, Osaka City University Medical School, Japan.

出版信息

Radiat Med. 1993 Nov-Dec;11(6):231-6.

PMID:7512271
Abstract

Fourteen patients with unrespectable HCC were treated with various interventional radiology (IVR) procedures. The initial therapeutic response was determined using computed tomography (CT) findings, and determinations of serum alpha-fetoprotein (AFP) and protein induced by Vitamin K absence or antagonist-II (PIVKA-II) levels. When CT studies of the initial response to IVR were compared with changes in the serum AFP and PIVKA-II levels, the AFP level was found to correlate more closely than the PIVKA-II levels. The PIVKA-II level correlated more closely than the AFP level in cases with poor response to IVR. Both of these tumor markers should be measured in combination with the diagnostic imagings for follow-up studies of IVR.

摘要

相似文献

1
Clinical evaluation of serum alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) levels in patients with hepatocellular carcinoma following interventional radiology.
Radiat Med. 1993 Nov-Dec;11(6):231-6.
2
Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma.蛋白质诱导的维生素K缺乏或拮抗剂II与甲胎蛋白在肝细胞癌中的临床病理意义
Int J Oncol. 1999 Feb;14(2):281-6. doi: 10.3892/ijo.14.2.281.
3
Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis.通过化学发光酶免疫测定法评估维生素K缺乏或拮抗剂-II诱导蛋白在检测肝细胞癌中的性能:一项荟萃分析。
Scand J Gastroenterol. 2018 Jun;53(6):734-740. doi: 10.1080/00365521.2018.1459824. Epub 2018 Apr 18.
4
Time courses of PIVKA-II and AFP levels after hepatic artery embolization and hepatic artery infusion against hepatocellular carcinoma: relation between the time course and tumor necrosis.肝动脉栓塞和肝动脉灌注治疗肝细胞癌后异常凝血酶原-II(PIVKA-II)和甲胎蛋白(AFP)水平的时间进程:时间进程与肿瘤坏死之间的关系
Radiat Med. 1992 Sep-Oct;10(5):189-95.
5
Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes.血浆去γ-羧基凝血酶原作为不同大小肿瘤患者肝细胞癌标志物蛋白的临床评价。
Dig Dis Sci. 1993 Dec;38(12):2170-6. doi: 10.1007/BF01299891.
6
Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients.维生素K缺乏或拮抗剂-II诱导蛋白(PIVKA-II)在意大利肝细胞癌患者中特异性升高。
Scand J Gastroenterol. 2016 Oct;51(10):1257-62. doi: 10.1080/00365521.2016.1183705. Epub 2016 May 26.
7
Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels.不同 AFP 和 PIVKA-II 血清水平组合的肝细胞癌的临床特征和预后。
Eur J Gastroenterol Hepatol. 2012 Jul;24(7):849-56. doi: 10.1097/MEG.0b013e3283535c34.
8
Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.甲胎蛋白及维生素K缺乏或拮抗剂-II诱导蛋白在乙型肝炎病毒相关肝细胞癌中的预后价值:一项前瞻性研究
J Clin Gastroenterol. 2009 May-Jun;43(5):482-8. doi: 10.1097/MCG.0b013e318182015a.
9
Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.肝细胞癌中的异常凝血酶原(脱γ-羧基凝血酶原)
Hepatogastroenterology. 1991 Oct;38(5):450-3.
10
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.PIVKA-II 可作为 AFP 的补充生物标志物,用于肝癌的诊断。
BMC Cancer. 2021 Apr 13;21(1):401. doi: 10.1186/s12885-021-08138-3.